ROYAL BANK OF CANADA - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$28,000
-72.3%
6,669
-60.0%
0.00%
Q4 2022$101,000
+320.8%
16,685
+295.9%
0.00%
Q3 2022$24,000
+700.0%
4,214
+644.5%
0.00%
Q2 2022$3,000566
+1216.3%
0.00%
Q1 2022$0430.0%0.00%
Q4 2021$043
-6.5%
0.00%
Q3 2021$046
+7.0%
0.00%
Q2 2021$0430.0%0.00%
Q1 2021$0
-100.0%
43
-80.9%
0.00%
Q4 2020$1,000225
+3.2%
0.00%
Q3 2020$0218
+407.0%
0.00%
Q2 2020$0430.0%0.00%
Q1 2020$0430.0%0.00%
Q4 2019$0430.0%0.00%
Q3 2019$0
-100.0%
43
-95.8%
0.00%
Q3 2018$2,000
+100.0%
1,024
+894.2%
0.00%
Q2 2018$1,000103
+157.5%
0.00%
Q4 2017$040
+122.2%
0.00%
Q3 2017$018
+100.0%
0.00%
Q1 2017$090.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders